Trials / Completed
CompletedNCT03076983
Assessment of the Capability of PulmoVista 500 to Continuously Monitor Changes of Ventilation Over Time
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Drägerwerk AG & Co. KGaA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The results of this study will help to define the capability and reliability of PulmoVista 500 to detect changes in both global and regional ventilation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lung Monitoring with EIT device (PulmoVista 500) | Patient's lungs will be monitored during clinical routine interventions with Dräger's EIT device (PulmoVista 500). No medical interventions to routine patient care required. |
Timeline
- Start date
- 2017-05-30
- Primary completion
- 2018-04-12
- Completion
- 2018-04-12
- First posted
- 2017-03-10
- Last updated
- 2019-11-27
- Results posted
- 2019-10-18
Locations
3 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT03076983. Inclusion in this directory is not an endorsement.